Skip to main content

DNA Day Essay Contest held by American Society of Human Genetics

Kids growing up in the Hermansky-Pudlak Syndrome or albinism communities have had a little more exposure to genetics than the average kids. I'm passing this along in hopes some of you will feel inspired to enter this contest.



The American Society of Human Genetics (ASHG) invites you to participate in the 5th Annual DNA Day Essay Contest! The contest is open to students in grades 9-12.



The contest aims to challenge students to examine, question, and reflect on the important concepts of genetics. Essays are expected to contain substantive, well-reasoned arguments indicative of a depth of understanding of the concepts related to the essay questions.


Essays are read and scored by at least two independent judges. A 1st, 2nd and 3rd place winner are chosen for each question.


1st Place Winner: $400 + teacher receives a $2,000 grant for laboratory genetics equipment.


2nd Place Winner: $250


3rd Place Winner: $150


This year you have two question options. Whichever you choose, remember to support your argument with citations from science articles, books, newspapers, etc. Take advantage of research published by experts, which is more reliable than open Web sources, blogs, or other references from people who lack specialized knowledge.




Option 1 In 2010, a major discovery in genetics research found that the DNA of some modern humans contains small amounts of Neanderthal DNA. Briefly explain this finding and discuss its relevance to human ancestry and evolution.


Option 2 A number of companies offer genetic testing directly to consumers, bypassing the involvement of physicians and genetic counselors. Discuss whether you think this is a good idea or not. You might focus on medical, ethical, legal, or social dimensions of this issue.


Submission Deadline: March 7, 2011. The submission site will be available in January 2011.
To learn more or to read the contest rules, go to: http://www.ashg.org/education/dnadaycontest.shtml






Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...